Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician

Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician

Teresa Semalulu,1 Achieng Tago,2 Kevin Zhao,3 Konstantinos Tselios1 1Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; 2Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; 3Michael G. DeGroote School of Medic...

Full description

Bibliographic Details
Main Authors:	Semalulu T, Tago A, Zhao K, Tselios K
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-12-01
Series:	ImmunoTargets and Therapy
Subjects:	cardiovascular disease atherosclerosis endothelial dysfunction coronary artery disease risk stratification prevention.
Online Access:	https://www.dovepress.com/managing-cardiovascular-risk-in-systemic-lupus-erythematosus-considera-peer-reviewed-fulltext-article-ITT

Similar Items

Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies
by: Aline M. A. Martins, et al.
Published: (2021-12-01)

Assessment of Arterial Stiffness and Biochemical Markers in Systemic Lupus Erythematosus in the Diagnosis of Subclinical Atherosclerosis
by: Dominika Blachut, et al.
Published: (2024-03-01)

Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease
by: Hilal Kurtoğlu Gümüşel, et al.
Published: (2014-07-01)

Endothelial Dysfunction, Erectile Deficit and Cardiovascular Disease: An Overview of the Pathogenetic Links
by: Federico De Leonardis, et al.
Published: (2022-08-01)

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation—A Multi‐Center Observational Cohort Study
by: Noriaki Tabata, et al.
Published: (2017-08-01)

Role of Vitamin D in Cardiovascular Diseases
by: Valentino Condoleo, et al.
Published: (2021-10-01)

Value of addition of coronary artery calcium to risk scores in the prediction of major cardiovascular events in patients with type 2 diabetes
by: Barak Zafrir, et al.
Published: (2021-11-01)

Can Erectile Dysfunction Predict Major Cardiovascular Events?
by: Szekeres Norbert A., et al.
Published: (2016-06-01)

Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications
by: Michael J. Blaha, et al.
Published: (2023-03-01)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
by: Joep van der Leeuw, et al.
Published: (2016-06-01)

Current Evidence and Future Perspectives of the Best Supplements for Cardioprotection: Have We Reached the Final Chapter for Vitamins?
by: Farah Yasmin, et al.
Published: (2022-11-01)

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases
by: Fabiola Atzeni, et al.
Published: (2018-02-01)

Correlation analysis between sleep quality and carotid atherosclerosis in low and moderate risk individuals for cardiovascular and cerebrovascular diseases
by: ZHAO Qian, et al.
Published: (2023-11-01)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
by: Teresa Salvatore, et al.
Published: (2021-09-01)

Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
by: T V Popkova, et al.
Published: (2004-08-01)

Cardiovascular diseases and erectile dysfunction
by: Svetlana Aleksandrovna Pomeshkina, et al.
Published: (2010-10-01)

Relationship between different cardiovascular risk scores and measures of subclinical atherosclerosis in an Indian population
by: Manish Bansal, et al.
Published: (2015-07-01)

Machine Learning Coronary Artery Disease Prediction Based on Imaging and Non-Imaging Data
by: Vassiliki I. Kigka, et al.
Published: (2022-06-01)

Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches
by: Diana Jhoseline Medina-Leyte, et al.
Published: (2021-04-01)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021-12-01)

Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease
by: Weiqian E. Lee, et al.
Published: (2023-06-01)

Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis
by: S. C. Bergkamp, et al.
Published: (2023-05-01)

Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease
by: Fujie Zhao, et al.
Published: (2022-06-01)

Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: A study in patients with first myocardial infarction
by: Manish Bansal, et al.
Published: (2014-11-01)

Pulse Wave Velocity in Atherosclerosis
by: Hack-Lyoung Kim, et al.
Published: (2019-04-01)

High‐Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study)
by: Nick S. R. Lan, et al.
Published: (2019-03-01)

New Trends in the Impact of Periodontal Treatment on Early Cardiovascular Diseases Outcomes: Insights and Future Perspectives
by: Mariacristina Amato, et al.
Published: (2023-10-01)

Development and Validation of Decision Rules Models to Stratify Coronary Artery Disease, Diabetes, and Hypertension Risk in Preventive Care: Cohort Study of Returning UK Biobank Participants
by: José Castela Forte, et al.
Published: (2021-12-01)

Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases
by: Shivan Barungi, et al.
Published: (2023-03-01)

Role of Traditional Cardiovascular Risk Factors for the Occurrence of Erectile Dysfunction in Patients with Coronary Artery Disease
by: Heri Hernawan, et al.
Published: (2017-04-01)

Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
by: Wolf-Henning Boehncke, et al.
Published: (2018-04-01)

Peripheral arterial disease: A small and large vessel problem
by: Monique Bethel, et al.
Published: (2023-04-01)

Freqüência de doença cardiovascular aterosclerótica e de seus fatores de risco em pacientes com lúpus eritematoso sistêmico Frequency of atherosclerotic cardiovascular disease and its risk factors in patients with systemic lupus erythematosus
by: Rosa Weiss Telles, et al.
Published: (2007-06-01)

Rheumatoid arthritis: influence of inflammation and anti-inflammatory therapy on cardiovascular risk factors
by: D. I. Trukhan, et al.
Published: (2020-08-01)

The significance of circulating progenitor cells with osteogenic activity in the of atherosclerosis development in patients with type 2 diabetes mellitus
by: Marina S. Michurova, et al.
Published: (2019-06-01)

Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling
by: Marie Besnier, et al.
Published: (2021-09-01)

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study
by: Martino Deidda, et al.
Published: (2022-01-01)

PREVENCIÓN SECUNDARIA EN LA ENFERMEDAD CORONARIA EN 2012: ANÁLISIS DE ALGUNOS ASPECTOS MÁS ALLÁ DE LA PRESCRIPCIÓN DE FÁRMACOS / Secondary prevention in coronary artery disease in 2012: Analysis of some issues beyond drug prescription
by: Eduardo F. Mele
Published: (2012-03-01)

Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction
by: Nadia Akhiyat, et al.
Published: (2022-04-01)

Assessment of biomarkers of endothelial dysfunction in patients with angiographically proven coronary artery disease
by: Sanjay G Guddetwar, et al.
Published: (2020-01-01)